Psychotropic medication and behaviours: Which behaviours are likely to be medication-responsive?

Date: 20 November 2020 - 20 December 2020
Location: Virtual
Venue: Online
Event type: Webinar
Psychotropic medication and behaviours: Which behaviours are likely to be medication-responsive?

 

WHO IS THIS WEBINAR FOR?

This session is for clinical staff working in residential care settings.

 

WEBINAR OVERVIEW

This module will support clinical staff to demonstrate leadership on best practice approaches to behaviour management and the appropriate use of psychotropic medication. It recognises the key role of clinical staff in influencing treatment decisions, outcomes and the overall approach to managing behaviour in residential care. The practical translation of knowledge gained in this module will assist care homes to meet the Aged Care Quality Standards (Standard 3 Personal care and clinical care).



WHY ATTEND?

At the end of this workshop participants will be able to:

  • Describe best practice approaches to behaviour management
  • Compare different types of BPSD and the degree of relevance of pharmacological and non-pharmacological interventions
  • Summarise the evidence base for psychotropic medications
  • Identify general principles of prescribing and advocate for review of medication
  • Recognise your role in providing leadership to reduce the inappropriate use of psychotropic medication



PRESENTER

Prof Steve Macfarlane - Head of Clinical Services, Dementia Support Australia

 rsz steve macfarlane

BIO

Steve graduated from Monash University in 1991, and spent 17 years at Peninsula Health in Melbourne, completing his psychiatry training there and becoming Director of Aged Psychiatry in 2005. He moved to Alfred Health in 2008 as Associate Professor and Director of Aged Psychiatry, before accepting as position as Head of Clinical Services with Dementia Support Australia in 2016.


Steve is the Chair of the Binational Faculty of Psychiatry of Old Age for the RANZCP, has been running Alzheimer’s disease clinical trials for over 20 years, and has clinical interests in frontal lobe disorders and in senile squalor.
His work with DSA has him overseeing a group of geriatricians and old-age psychiatrists working around the country, and he has been intimately involved with the development of the proposed new Commonwealth Special Dementia Care Programme and with the Royal Commission into Aged Care Safety and Quality, testifying before the Royal Commission in May 2019 and July 2020.

Psychotropic medication and behaviours: Which behaviours are likely to be medication-responsive?